PHARMACEUTICAL INDUSTRY IN EAST AFRICA, 2007

1
 KENYA
PHARMACEUTICAL MARKET OVERVIEW KENYA

KENYAN PHARMACEUTICAL MARKET,

2007
USD 210 Mn

MARKET BY SEGMENT MARKET BY SOURCE

BRANDED
44% DOMESTIC
28%
MNC
72%
GENERIC
CAGR|
56%
(2007-2014)
15%

KENYAN PHARMACEUTICAL MARKET,

2014
USD 560 Mn
 TANZANIA
PHARMACEUTICAL MARKET OVERVIEW TANZANIA

TANZANIA PHARMACEUTICAL MARKET,

2007
USD 105 Mn

MARKET BY SEGMENT MARKET BY SOURCE

BRANDED
46% DOMESTIC
31% MNC
69%
GENERIC
CAGR|
54%
(2007-2014)
9%

TANZANIA PHARMACEUTICAL MARKET,

2014
USD 190 Mn
 UGANDA
PHARMACEUTICAL MARKET OVERVIEW UGANDA

UGANDA PHARMACEUTICAL MARKET,

2007
USD 85 Mn

MARKET BY SEGMENT MARKET BY SOURCE

BRANDED
20% DOMESTIC
10%

GENERIC CAGR|
80% MNC
(2007-2014)
90%
8.5%

UGANDA PHARMACEUTICAL MARKET,

2014
USD 150 Mn
EAST AFRICA
REGULATORY FRAMEWORK AND TIME LINE FOR NEW
PRODUCT REGISTRATION
REGULATORY
COUNTRY KRAs TIME LINE
BODY

Responsible for the registration and quality control

The Pharmacy and of
KENYA 3-6 MONTHS
Poisons Board pharmaceuticals, licensing of pharmaceuticals and
advertising of
(PPB) drugs.

Tanzania Food Responsible for registration and licensing of

and Drugs |
manufacturing sites, entry ports pharmaceutical and
TANZANIA Authority medical device products.
8-12 MONTHS
(TFDA) • Also regulates import and export of registered
products.

The National Drug Authority (NDA) is an

autonomous body set up by the government to
implement the National Drug Policy based on the
National Drug concept of Essential Drugs. NDA is the guardian of
UGANDA Authority (NDA) public interest concerning drugs. Any drug 8-12 MONTHS
promotion information reaching the public in Uganda
must first be vetted by and obtain approval from
NDA.
 THANK YOU
|
ManasRanjan Rout
Pharmaceutical and Healthcare Professional, Kenya
Email: healthcaremanas@in.com